- Home
- GIFT vs OSTX Comparison
GIFT vs OSTX Comparison
Compare GIFT & OSTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIFT
- OSTX
- Stock Information
- Founded
- GIFT 1999
- OSTX 2018
- Country
- GIFT United States
- OSTX United States
- Employees
- GIFT N/A
- OSTX N/A
- Industry
- GIFT Catalog/Specialty Distribution
- OSTX
- Sector
- GIFT Consumer Discretionary
- OSTX
- Exchange
- GIFT Nasdaq
- OSTX NYSE
- Market Cap
- GIFT 51.0M
- OSTX 43.0M
- IPO Year
- GIFT N/A
- OSTX 2024
- Fundamental
- Price
- GIFT $1.40
- OSTX $1.82
- Analyst Decision
- GIFT Strong Buy
- OSTX Strong Buy
- Analyst Count
- GIFT 1
- OSTX 3
- Target Price
- GIFT $4.00
- OSTX $18.00
- AVG Volume (30 Days)
- GIFT 71.4K
- OSTX 319.8K
- Earning Date
- GIFT 05-13-2025
- OSTX 05-16-2025
- Dividend Yield
- GIFT N/A
- OSTX N/A
- EPS Growth
- GIFT N/A
- OSTX N/A
- EPS
- GIFT N/A
- OSTX N/A
- Revenue
- GIFT $89,689,155.00
- OSTX N/A
- Revenue This Year
- GIFT $12.22
- OSTX N/A
- Revenue Next Year
- GIFT N/A
- OSTX N/A
- P/E Ratio
- GIFT N/A
- OSTX N/A
- Revenue Growth
- GIFT 6.13
- OSTX N/A
- 52 Week Low
- GIFT $0.50
- OSTX $1.12
- 52 Week High
- GIFT $4.22
- OSTX $7.00
- Technical
- Relative Strength Index (RSI)
- GIFT N/A
- OSTX N/A
- Support Level
- GIFT N/A
- OSTX N/A
- Resistance Level
- GIFT N/A
- OSTX N/A
- Average True Range (ATR)
- GIFT 0.00
- OSTX 0.00
- MACD
- GIFT 0.00
- OSTX 0.00
- Stochastic Oscillator
- GIFT 0.00
- OSTX 0.00
About GIFT RDE Inc. Common Stock
Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.
About OSTX OS THERAPIES INCORPORATED
OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The companys mission is to address the need for new treatments in cancers of the bone in children and young adults.